Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 33-36, 2015.
Article Dans Chinois | WPRIM | ID: wpr-312983

Résumé

<p><b>OBJECTIVE</b>To study the effect of bitter-cold herbs easing dampness method (BCHEDM) plus Sanhuang Yilong Decoction (SYD) combined with methotrexate (MTX) on expression levels of interleukin-1 (IL-1), IL-6, and IL-17 in rheumatoid arthritis (RA) patients of accumulated dampness-heat syndrome (ADHS).</p><p><b>METHODS</b>From January 2011 to January 2013 recruited were 90 RA inpatients of ADHS at Department of Integrative Medicine on Rheumatoid Disease, General Hospital of Chengdu Military Region. They were assigned to the treatment group (45 cases) and the control group (45 cases) according to the random digit table produced by SPSS 11.5 Software. Patients in the treatment group were treated by heavy bitter-cold herbs plus SYD combined with MTX, while those in the control group were treated by MTX alone. Expressional levels of IL-1, IL-6, and IL-17 in serum were detected by enzyme linked immunosorbent assay (ELISA) before treatment, at week 2 and 4 after treatment. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and disease activity score in 28 joints (DAS28) were detected as well.</p><p><b>RESULTS</b>After two or four weeks of treatment, ESR, CRP, and DAS28 decreased more in the treatment group than in the control group with statistical difference (P < 0.05, P < 0.01). After four weeks of treatment, IL-1, IL-6, IL-17, ESR, CRP, and DAS28 in the treatment group were all lower than before treatment and those of the control group at corresponding time points with statistical difference (P < 0.01).</p><p><b>CONCLUSION</b>SYD combined MTX could play roles of improving inflammatory indices within 2 weeks, and inhibiting the expression of IL-1, IL-6, and IL-17 within 4 weeks.</p>


Sujets)
Humains , Polyarthrite rhumatoïde , Sang , Traitement médicamenteux , Allergie et immunologie , Sédimentation du sang , Protéine C-réactive , Association de médicaments , Médicaments issus de plantes chinoises , Utilisations thérapeutiques , Température élevée , Interleukine-1 , Sang , Interleukine-17 , Sang , Interleukine-6 , Sang , Méthotrexate , Utilisations thérapeutiques , Syndrome , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche